Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930839 · ClinicalTrials.gov registry record
Role of Prostaglandins on Niacin-Induced Flushing
A clinical trial, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- 30
- Enrollment target
NCT00930839: Completed study, sponsored by Eastern Virginia Medical School.
NCT00930839 is a clinical trial that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00930839 has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will focus on investigating the nicotinic acid stimulated release of prostaglandin D2 in normal controls. In subsequent studies, the investigators would like to further explore this pathway in people with type 2 diabetes. Enhanced blood flow (or flushing) may be compromised or exaggerated in type 2 diabetes particularly in those with impairment of autonomic function measured as the respiratory heart rate variability (HRV) of different frequencies reflecting the balance between the sympathetic and parasympathetic nervous systems. The investigators hypothesize that the vasodilatory effects induced by nicotinic acid will be different in glabrous and hairy skin and that autonomic imbalance may alter the response.
Interventions
- DRUG Niacin and aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
What the finished NCT00930839 record still lists
NCT00930839 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Niacin and aspirin is the first listed.
NCT00930839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00930839 about?
NCT00930839 is a clinical study titled "Role of Prostaglandins on Niacin-Induced Flushing". This study will focus on investigating the nicotinic acid stimulated release of prostaglandin D2 in normal controls. In subsequent studies, the investigators would like to further explore this pathway in people with type 2 diabetes. Enhanced blood flow (or flushing) may be compromised or exaggerated...
What is the current status of trial NCT00930839?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00930839?
The interventions under investigation include: Niacin and aspirin (DRUG).
Who is sponsoring clinical trial NCT00930839?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia